NOVAVAX INC's ticker is NVAXXXXX and the CUSIP is 670002104. A total of 141 filers reported holding NOVAVAX INC in Q4 2017. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $14,000 | +600.0% | 49,200 | +1809.9% | 0.00% | – |
Q4 2017 | $2,000 | 0.0% | 2,576 | 0.0% | 0.00% | – |
Q3 2017 | $2,000 | -83.3% | 2,576 | -78.8% | 0.00% | – |
Q2 2017 | $12,000 | -20.0% | 12,176 | -69.5% | 0.00% | -100.0% |
Q1 2017 | $15,000 | -82.6% | 39,976 | -69.3% | 0.00% | -66.7% |
Q4 2016 | $86,000 | +1.2% | 130,305 | +1.5% | 0.00% | 0.0% |
Q3 2016 | $85,000 | -70.6% | 128,329 | +35.2% | 0.00% | -80.0% |
Q2 2016 | $289,000 | +63.3% | 94,905 | +27.9% | 0.02% | +25.0% |
Q1 2016 | $177,000 | -27.5% | 74,205 | -49.9% | 0.01% | -14.3% |
Q4 2015 | $244,000 | – | 148,005 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Caption Management, LLC | 2,021,600 | $22,273,000 | 1.23% |
GREAT POINT PARTNERS LLC | 4,500,000 | $2,479,000 | 0.24% |
SABBY MANAGEMENT, LLC | 860,000 | $474,000 | 0.23% |
Sargent Investment Group, LLC | 588,070 | $324,000 | 0.16% |
BB BIOTECH AG | 8,330,000 | $4,589,000 | 0.12% |
GREAT POINT PARTNERS LLC | 2,000,000 | $1,102,000 | 0.11% |
CENTAURUS FINANCIAL, INC. | 7 | $12,000,000 | 0.07% |
Rock Springs Capital Management LP | 3,250,000 | $1,790,000 | 0.07% |
Beirne Wealth Consulting Services, LLC | 155,000 | $85,000 | 0.07% |
ACUTA CAPITAL PARTNERS, LLC | 250,000 | $138,000 | 0.07% |